Sen. Cortez Masto Pushes Lower Drug Costs for Families Act to Curb Price Hikes in Private Insurance
This bill is currently in the early stages of the legislative process. It was recently introduced in the Senate and sent to the Committee on Finance for review. No further actions are scheduled at this time.
This bill faces a tough path because it expands government price controls into the private market. It currently lacks the bipartisan support needed to pass through a divided Senate.
This bill’s path across every version that has carried it.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Small business owners who provide health insurance to their employees could see slower growth in prescription drug costs within their health plans. Rising drug prices are a major driver of premium increases, and capping price growth at the rate of inflation could ease pressure on employer-sponsored insurance costs over time.
Read twice and referred to the Committee on Finance.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Lower Drug Costs for Families Act
Analysis generated by AI. Always verify with official sources.
